Intermittent parathyroid hormone (PTH) administration has been shown to be a promising therapy for systemic bone loss. Accordingly, we hypothesized that PTH could have positive results in treating oral complications of osteoporosis. Hence, we evaluated both mandibular bone loss and its response to PTH in a rabbit model of osteoporosis induced by ovariectomy and glucocorticoid administration. There was a significant and marked decrease in bone mineral density (BMD), bone mineral content (BMC), and calcium content in ash from the osteoporotic peri-alveolar region, which influenced global jaw loss. Remarkably, PTH (1–34) administration to osteoporotic rabbits almost completely reversed BMD, BMC, and calcium content fall in the peri-alveolar region, subsequently reducing global mandibular bone loss. Thus, although the peri-alveolar region is particularly susceptible to osteoporosis, it also responds well to intermittent PTH. Therefore, these results suggest that PTH might represent a valid therapy for improving the osseointegration of dental implants in persons with osteoporosis.
Get full access to this article
View all access options for this article.
References
1.
Binte Anwar R, Tanaka M, Kohno S, Ikegame M, Watanabe N, Nowazesh Ali M, et al. (2007). Relationship between porotic changes in alveolar bone and spinal osteoporosis. J Dent Res86:52–57.
2.
Calvo E, Castañeda S, Largo R, Fernández-Valle ME, Rodríguez-Salvanés F, Herrero-Beaumont G (2007). Osteoporosis increases the severity of cartilage damage in an experimental model of osteoarthritis in rabbits. Osteoarthritis Cartilage15:69–77.
3.
Castañeda S, Largo R, Calvo E, Rodríguez-Salvanés F, Marcos ME, Díaz-Curiel M, et al. (2006). Bone mineral measurements of subchondral and trabecular bone in healthy and osteoporotic rabbits. Skeletal Radiol35:34–41.
4.
Castañeda S, Calvo E, Largo R, González-González R, De la Piedra C, Díaz-Curiel M, et al. (2008). Characterization of a new experimental model of osteoporosis in rabbits. J Bone Miner Metab26:53–59.
5.
D’Amelio P, Panattoni GL, Di Stefano M, Nassisi R, Violino D, Isaia GC (2002). Densitometric study of dry human mandible. J Clin Densitom5:363–367.
6.
Ejiri S, Tanaka M, Watanabe N, Anwar RB, Yamashita E, Yamada K, et al. (2008). Estrogen deficiency and its effect on the jaw bones. J Bone Miner Metab26:409–415.
7.
Gilsanz V, Roe TF, Gibbens DT, Schulz EE, Carlson ME, Gonzalez O, et al. (1988). Effect of sex steroids on peak bone density of growing rabbits. Am J Physiol Endocrinol Metab255(4 Pt 1):E416–E421.
8.
Hess LM, Jeter JM, Benham-Hutchins M, Alberts DS (2008). Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med121:475–483.
9.
Hodsman AB, Bauer DC, Dempster DW, Dian L, Hanley DA, Harris ST, et al. (2005). Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev26:688–703.
10.
Horner K, Devlin H, Alsop CW, Hodgkinson IM, Adams JE (1996). Mandibular bone mineral density as a predictor of skeletal osteoporosis. Br J Radiol69:1019–1025.
11.
Hunziker J, Wronski TJ, Miller SC (2000). Mandibular bone formation rates in aged ovariectomized rats treated with anti-resorptive agents alone and in combination with intermittent parathyroid hormone. J Dent Res79:1431–1438.
12.
Jiang GZ, Matsumoto H, Hori M, Gunji A, Hakozaki K, Akimoto Y, et al. (2008). Correlation among geometric, densitometric, and mechanical properties in mandible and femur of osteoporotic rats. J Bone Miner Metab26:130–137.
13.
Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC (1999). Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest104:439–446.
14.
Johnson RB, Gilbert JA, Cooper RC, Dai X, Newton BI, Tracy RR, et al. (1997). Alveolar bone loss one year following ovariectomy in sheep. J Periodontol68:864–871.
15.
Johnson RB, Gilbert JA, Cooper RC, Parsell DE, Stewart BA, Dai X, et al. (2002). Effect of estrogen deficiency on skeletal and alveolar bone density in sheep. J Periodontol73: 383–391.
16.
Kaye EK (2007). Bone health and oral health. J Am Dent Assoc138: 616–619.
17.
Kingsmill VJ, Boyde A (1999). Mineralisation density and apparent density of bone in cranial and postcranial sites in the ageing human. Osteoporos Int9:260–268.
18.
Kuroda S, Mukohyama H, Kondo H, Aoki K, Ohya K, Ohyama T, et al. (2003). Bone mineral density of the mandible in ovariectomized rats: analyses using dual energy x-ray absorptiometry and peripheral quantitative computed tomography. Oral Dis9:24–28.
19.
Lerouxel E, Libouban H, Moreau MF, Baslé MF, Audran M, Chappard D (2004). Mandibular bone loss in an animal model of male osteoporosis (orchidectomized rat): a radiographic and densitometric study. Osteoporos Int15:814–819.
20.
Lindsay R, Cosman F, Zhou H, Bostrom MP, Shen VW, Cruz JD, et al. (2006). A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide. J Bone Miner Res21: 366–373.
21.
Ma YL, Zeng Q, Donley DW, Ste-Marie LG, Gallagher JC, Dalsky GP, et al. (2006). Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis. J Bone Miner Res21:855–864.
22.
Mashiba T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM (2001). Effects of human parathyroid hormone (1–34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits. Bone28:538–547.
23.
Mavropoulos A, Rizzoli R, Ammann P (2007). Different responsiveness of alveolar and tibial bone to bone loss stimuli. J Bone Miner Res22: 403–410.
24.
Miller SC, Hunziker J, Mecham M, Wronski TJ (1997). Intermittent parathyroid hormone administration stimulates bone formation in the mandibles of aged ovariectomized rats. J Dent Res76:1471–1476.
25.
Moreno-Torres R, Navarro M, Ruiz-Lopez MD, Artacho R, Lopez C (2000). Comparison of wet and dry mineralisation procedures for determining calcium and phosphorus in cow’s milk. Austral J Dairy Technol55:23–27.
26.
Mulder L, van Groningen LB, Potgieser YA, Koolstra JH, van Eijden TM (2006). Regional differences in architecture and mineralization of developing mandibular bone. Anat Rec A Discov Mol Cell Evol Biol288:954–961.
27.
Ouyang H, McCauley LK, Berry JE, D’Errico JA, Strayhorn CL, Somerman MJ (2000). Response of immortalized murine cementoblasts/periodontal ligament cells to parathyroid hormone and parathyroid hormone-related protein in vitro. Arch Oral Biol45:293–303.
28.
Raisz LG (2005). Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest115:3318–3325.
29.
Sidiropoulou-Chatzigiannis S, Kourtidou M, Tsalikis L (2007). The effect of osteoporosis on periodontal status, alveolar bone and orthodontic tooth movement. A literature review. J Int Acad Periodontol9:77–84.
30.
Streckfus CF, Johnson RB, Nick T, Tsao A, Tucci M (1997). Comparison of alveolar bone loss, alveolar bone density, salivary and gingival crevicular fluid IL-6 concentrations in healthy premenopausal and postmenopausal women on estrogen therapy. J Gerontol A Biol Sci Med Sci52:343–351.
31.
Taguchi A, Tanimoto K, Suei Y, Ohama K, Wada T (1996). Relationship between the mandibular and lumbar vertebral bone mineral density at different postmenopausal stages. Dentomaxillofac Radiol25:130–135.
32.
Tanaka M, Ejiri S, Toyooka E, Kohno S, Ozawa H (2002). Effects of ovariectomy on trabecular structures of rat alveolar bone. J Periodontal Res37:161–165.
33.
Turner AS (2001). Animal models of osteoporosis—necessity and limitations. Eur Cell Mater1:66–81.
34.
Van Eijden TM, van der Helm PN, van Ruijven LJ, Mulder L (2006). Structural and mechanical properties of mandibular condylar bone. J Dent Res85:33–37.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
